Core Concept & Value Proposition
BetweenVisits is a lightweight SaaS platform that bridges the 90-day silence between a diabetes patient's endocrinology appointments. It automatically ingests a patient's continuous glucose monitor (CGM) data, uses AI to detect meaningful patterns, and delivers a plain-English weekly "glucose coach letter" to the patient via email — plus a structured, one-page AI-generated briefing document to their care team before each appointment.
The core insight: diabetes patients have more data than ever but almost no interpretation, coaching, or feedback until they sit in a doctor's office for 15 minutes every few months. BetweenVisits fills that gap with zero app-opening required.
The Problem Being Solved
- Patients with Type 1 and Type 2 diabetes make 180+ daily micro-decisions about food, insulin, and activity — with almost no expert feedback between quarterly appointments
- Endocrinologists spend the first 10-12 minutes of every appointment just reviewing raw CGM graphs and data dumps — time stolen from actual care conversations
- Generic nutrition and glucose apps give population-level averages, not personalized pattern analysis
- Decision fatigue and lack of actionable feedback are primary drivers of poor long-term adherence and outcomes
How It Works (Product Overview)
- Step 1 — Connect: Patient connects their CGM device (Dexcom G6/G7 or FreeStyle Libre via API or CSV export for MVP)
- Step 2 — Analyze: The system runs weekly automated analysis detecting patterns such as post-meal spikes, dawn phenomenon, overnight lows, time-in-range trends, and correlations with logged meals or activity
- Step 3 — Coach Letter: Every Sunday evening, the patient receives a friendly, plain-English email summarizing their week: "Your mornings are your strongest window — time-in-range before 10am was 94%. Your post-dinner numbers spiked above 180 on 4 of 7 days, likely tied to your logged evening meals."
- Step 4 — Appointment Brief: Two days before a scheduled appointment, the system auto-generates a structured one-page PDF/email summary for the endocrinologist showing 90-day trends, top 3 patterns, and flagged anomalies — saving the doctor significant review time
AI & Technology Stack
- LLM narrative generation: GPT-4o or Claude Haiku takes structured pattern outputs and generates warm, personalized, non-clinical coaching language for the patient emails
- Pattern detection: A lightweight rule-based + statistical ML layer identifies meaningful glucose patterns (threshold crossings, variance trends, time-of-day clustering) — no black box, interpretable outputs
- Email delivery: Resend for transactional and coaching emails (directly inspired by modern AI newsletter infrastructure)
- Backend: Vercel + Supabase for rapid deployment; HIPAA-eligible infrastructure from day one via Supabase's BAA option
- Integrations: Dexcom Clarity Developer API (available), FreeStyle LibreView CSV export for MVP fallback
MVP Scope (What to Build First)
The MVP is intentionally narrow and shippable in 6-8 weeks by a team of 2:
- CSV upload flow for CGM data (no API integration needed at launch)
- 5 core pattern detectors: time-in-range %, post-meal spike frequency, overnight low events, morning baseline trend, week-over-week trend
- Weekly coach email template powered by LLM narrative layer
- Simple web dashboard showing the last 4 weeks of pattern summaries
- Pre-appointment one-page PDF export
- Stripe subscription at $12/month for patients
What is explicitly NOT in the MVP: native mobile app, real-time alerts, food logging, insulin dose tracking, clinic portal — all Phase 2+
Unique Selling Points
- Zero new habit required: Patients receive value in their inbox — no app to open, no dashboard to remember to check
- Dual value creation: Simultaneously makes the patient's life less overwhelming AND makes the endocrinologist's appointment dramatically more efficient
- Personalized, not generic: Patterns are derived from the individual patient's own data history, not population averages
- Regulatory-safe positioning for MVP: Framed as wellness insights and data organization, not medical diagnosis or prescription — avoids FDA Class II device classification at launch
- Inspired by the Allergo model: Solving a chronic condition management problem at the exact moment of need, with minimal friction
Business Model
- Patient tier: $12/month subscription — weekly coach letters + appointment briefs
- Clinic tier (Phase 2): $99/month per provider — dashboard showing all connected patients' upcoming appointment briefs, aggregate population health signals
- Potential partnership: Integration with endocrinology practices as a value-add tool they recommend to patients (B2B2C distribution)
Market Opportunity & Impact
- 37 million Americans have diabetes; approximately 8 million use CGM devices — a well-defined, reachable early adopter pool
- Even capturing 0.1% of CGM users = 8,000 paying customers = ~$1.1M ARR
- Meaningfully improves time-in-range adherence and appointment quality — measurable health outcomes that support insurance reimbursement conversations in later stages
- Directly reduces the cognitive and emotional burden that leads to diabetes burnout, a clinically recognized and undertreated condition